| Oracle® Clinical Development Analytics Release Notes Release 2.0.0.2 Part Number E18333-04 |
|
| View PDF |
| Oracle® Clinical Development Analytics Release Notes Release 2.0.0.2 Part Number E18333-04 |
|
| View PDF |
Release Notes
Release 2.0.0.2
E18333-04
March 2011
This document provides a complete, up-to-date description of Oracle Clinical Development Analytics (OCDA) Release 2.0.0.2. You should read and understand all tasks described here before you begin your installation. The most current version of this About Oracle Clinical Development Analytics Release 2.0.0.2 document is available on Oracle Technology Network. Ensure that you have the most current version before you begin.
This document contains the following information about OCDA Release 2.0.0.2:
This document describes OCDA Release 2.0.0.2. You can find related information about this product by referring to the most recent version of your OCDA user and implementation documentation. For a list of available OCDA documentation, refer to Implementation and User Documentation.
For more information about OCDA certification, visit My Oracle Support. To find certification information on My Oracle Support:
Sign in to My Oracle Support at http://support.oracle.com.
Click the Certifications tab.
The Certifications page opens and displays the Find Certifications region.
In Select Product, enter Oracle Clinical Development Analytics.
Click the Go to Certifications icon.
The right pane displays the certification information.
Select a certification to view the certification details.
There are no new or changed features in OCDA Release 2.0.0.2.
New scripts have been added for post installation tasks andexisting scripts have been enhaced for performance improvements.
Before you apply the OCDA 2.0.0.2 patch, ensure that you install Oracle Clinical Development Analytics Release 2.0 and OCDA 2.0.0.1 patch. Refer to the Oracle Clinical Development Analytics Installation Guide Release 2.0.0.2 (Part E18163-04) for detailed instructions on how to install, set up, and upgrade the OCDA application.
The following OCDA Release 2.0.0.2 user documentation is available:
Oracle Clinical Development Analytics Installation Guide (Part E18163-04)
Oracle Clinical Development Analytics User and Administrator Guide (Part E18162-03)
Oracle Clinical Development Analytics Electronic Technical Reference Manual
| Bug Number | Description |
|---|---|
|
10238652 |
RE-SEQUENCE THE EXECUTION OF SECURITY PROGRMA WITHIN CONTEXT OF MASTER PROGRAM |
|
10253496 |
SITE ENRL TABLE DESCRIPTOR IS MISSING FROM OCDA_PLS_LEVEL1_FACT_PRG |
|
10301063 |
OCDA_S_PARTY_LS CANT BE CALLED AS BACKCHAIN SUBMISSION FOR ITS PARENT PROGRAM. |
|
10301098 |
PARAMETERS FOR SUB LEVEL MASTER AND SECURITY PROGRAMS ARE MISSING. |
|
10301286 |
CONSTRAINTS(INDEXES) ARE MISSING FOR THREE SECURITY PROGRAMS AND AGGREGATE FACTS |
|
10301329 |
IMPROVE MASTER PROGRAM BY SEQUENCING SEC PRGS TO CUT DOWN NUMBER RE-EXECUTIONS |
|
11722994 |
ENABLE AND DISABLE SCRIPT NEEDS TO BE IMPROVED. QUERIES ARE GOING FOR FTS |
|
11723020 |
SIEBEL SOURCE 8.0.X DATAMODEL IS NOT IN SYNC WITH THE OCDA LSH DATAMODEL. |
|
11723120 |
OCDA_INFA_CRF_DIM_SDE_POOL_PRG THE SEQUENCE OF MAPPING AND WORK FLOW |
|
11723192 |
CREATSCRIPT FOR PMERR% TABLES AND PERMISSIONS NEEDED FOR THEM |
|
11067294 |
M-SST44 & M-SST42 DISPLAYING NULL VALUES |
Our goal is to make Oracle products, services, and supporting documentation accessible to all users, including users that are disabled. To that end, our documentation includes features that make information available to users of assistive technology. This documentation is available in HTML format, and contains markup to facilitate access by the disabled community. Accessibility standards will continue to evolve over time, and Oracle is actively engaged with other market-leading technology vendors to address technical obstacles so that our documentation can be accessible to all of our customers. For more information, visit the Oracle Accessibility Program Web site at http://www.oracle.com/accessibility/.
Accessibility of Code Examples in Documentation
Screen readers may not always correctly read the code examples in this document. The conventions for writing code require that closing braces should appear on an otherwise empty line; however, some screen readers may not always read a line of text that consists solely of a bracket or brace.
Accessibility of Links to External Web Sites in Documentation
This documentation may contain links to Web sites of other companies or organizations that Oracle does not own or control. Oracle neither evaluates nor makes any representations regarding the accessibility of these Web sites.
Oracle customers have access to electronic support through My Oracle Support. For information, visit http://www.oracle.com/support/contact.html or visit http://www.oracle.com/accessibility/support.html if you are hearing impaired.
Oracle Clinical Development Analytics Release Notes, Volume 1, Release 2.0.0.2
E18333-04
Copyright © 2009, 2011, Oracle and/or its affiliates. All rights reserved.
This software and related documentation are provided under a license agreement containing restrictions on use and disclosure and are protected by intellectual property laws. Except as expressly permitted in your license agreement or allowed by law, you may not use, copy, reproduce, translate, broadcast, modify, license, transmit, distribute, exhibit, perform, publish, or display any part, in any form, or by any means. Reverse engineering, disassembly, or decompilation of this software, unless required by law for interoperability, is prohibited.
The information contained herein is subject to change without notice and is not warranted to be error-free. If you find any errors, please report them to us in writing.
If this software or related documentation is delivered to the U.S. Government or anyone licensing it on behalf of the U.S. Government, the following notice is applicable:
U.S. GOVERNMENT RIGHTS Programs, software, databases, and related documentation and technical data delivered to U.S. Government customers are "commercial computer software" or "commercial technical data" pursuant to the applicable Federal Acquisition Regulation and agency-specific supplemental regulations. As such, the use, duplication, disclosure, modification, and adaptation shall be subject to the restrictions and license terms set forth in the applicable Government contract, and, to the extent applicable by the terms of the Government contract, the additional rights set forth in FAR 52.227-19, Commercial Computer Software License (December 2007). Oracle USA, Inc., 500 Oracle Parkway, Redwood City, CA 94065.
This software is developed for general use in a variety of information management applications. It is not developed or intended for use in any inherently dangerous applications, including applications which may create a risk of personal injury. If you use this software in dangerous applications, then you shall be responsible to take all appropriate fail-safe, backup, redundancy, and other measures to ensure the safe use of this software. Oracle Corporation and its affiliates disclaim any liability for any damages caused by use of this software in dangerous applications.
Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.
This software and documentation may provide access to or information on content, products, and services from third parties. Oracle Corporation and its affiliates are not responsible for and expressly disclaim all warranties of any kind with respect to third-party content, products, and services. Oracle Corporation and its affiliates will not be responsible for any loss, costs, or damages incurred due to your access to or use of third-party content, products, or services.
 Copyright © 2009, 2011, Oracle and/or its affiliates. All rights reserved. Legal Notices |
|